Hervé Tilly
埃尔韦·蒂利
MD, PhD
Head, Department of Hematology; Professor of Hematology, University of Rouen血液科主任；鲁昂大学血液学教授
👥Biography 个人简介
Hervé Tilly, MD, PhD is Head of Hematology at Centre Henri Becquerel, Rouen, and a leading figure in the LYSA cooperative group. He was coordinating investigator of the POLARIX trial and has led seminal LYSA studies on dose-dense R-CHOP and novel consolidation strategies, shaping frontline DLBCL treatment across Europe.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
POLARIX Trial Coordination
Served as coordinating principal investigator of POLARIX, the global phase III trial that positioned pola-R-CHP as a new standard of care over R-CHOP for previously untreated intermediate/high-risk DLBCL.
LYSA Frontline DLBCL Trial Program
Led LYSA-sponsored trials evaluating dose-dense R-CHOP-14, consolidation maintenance, and treatment intensification strategies in young high-risk DLBCL patients.
Representative Works 代表性著作
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma (POLARIX)
New England Journal of Medicine (2022)
Global phase III trial coordinated by Tilly demonstrating pola-R-CHP superiority over R-CHOP as first-line DLBCL treatment.
Diffuse large B-cell lymphoma: ESMO Clinical Practice Guidelines
Annals of Oncology (2015)
Comprehensive ESMO guidelines for DLBCL diagnosis, staging, and treatment written under Tilly's lead authorship.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 埃尔韦·蒂利 的研究动态
Follow Hervé Tilly's research updates
留下邮箱，当我们发布与 Hervé Tilly（Centre Henri Becquerel, Rouen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment